Author:
Buenrostro Gaitán Alicia,Sánchez Miranda Yerania,Juárez Ortiz Carlos
Reference36 articles.
1. Altit G, Dancea A, Renaud C, Perreault T, Lands LC, SantAnna G. Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature. Paediatr Respir Rev 2017;23:1626. doi: 10.1016/j.prrv.2016.11.002.
2. Amin RS, Rut ter MJ. Airway disease and management in bronchopulmonary dysplasia. Clin Perinatol 2015;42(4):857-870. doi: 10.1016/j.clp.2015.08.011.
3. Baker CD, Alvira CM. Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration. Curr Opin Pediatr 2014;26(3):306314. doi: 10.1097/MOP.0000000000000095.
4. Barrington KJ, Fortin-Pellerin E, Pennaforte T. Fluid restriction for treatment of preterm infants with chronic lung disease. Cochrane Database Syst Rev 2017;2:CD005389. doi: 10.1002/14651858.CD005389.pub2.
5. Bates ML, Pillers D-AM, Palta M, Farrell ET, Eldridge MW. Ventilatory control in infants, children, and adults with bronchopulmonary dysplasia. Respir Physiol Neurobiol 2013;189(2):329337. doi: 10.1016/j. resp.2013.07.015.